Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasm Metastasis 1 Glioblastoma 1 Astrocytoma 1

Interventions

Cyclophosphamide 11 fludarabine 8 Dexamethasone 7 pomalidomide 6 pembrolizumab 6 Rituximab 5 obinutuzumab 4 glofitamab 4 daratumumab 4 Immunotherapy, Adoptive 4 Gemcitabine 4 Bortezomib 4 venetoclax 3 selinexor 3 fludarabine phosphate 3 cemiplimab 3 Temozolomide 3 Nivolumab 3 Melphalan 3 Injections 3 Etoposide 3 zanubrutinib 2 tocilizumab 2 pirtobrutinib 2 blinatumomab 2 abemaciclib 2 Sirolimus 2 Oxaliplatin 2 Mesna 2 Lisaftoclax 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × AZD1390 × 30 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡